Global Asthma Epidemiology and Patient Flow Analysis - 2016
Fore Pharma announced the results of its Asthma patient population study in a new report ‘Global Asthma Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Asthma epidemiology, Asthma diagnosed patients, and Asthma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Asthma derived from epidemiological analysis, percentage of patients diagnosed with Asthma, and percentage of patients treated with Asthma therapy.
The study helps executives estimate Asthma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Asthma prevalence, Asthma diagnosis rate, and Asthma treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.